China Pharmaceutical International and BDHI Reach Cooperation Intention

On March 19, 2019, Bing Yan and Liuqin Yang, deputy general managers of SinoPharm International , the wholly-owned subsidiary of China's largest medical group, met with members of the board of directors of BDHI in Shanghai, China. The two sides reached an intention for all-round cooperation. The two sides first exchanged the company's development and highly appreciated their achievements in their respective countries and their outstanding contributions to society. The two sides found that they had similar business philosophy, similar values and full confidence in the future of cooperation. The two sides discussed medical supply chain cooperation, medical technology training, telemedicine cooperation, clinical cooperation and research in detail. They agreed that each other's advantages complement each other and win-win results can be achieved through close cooperation. Both sides agreed to follow up after the meeting and hope to sign the cooperation agreement as soon as possible.